OncoMed Pharmaceuticals Inc. , a clinical-stage company developing novel therapeutics that target cancer stem cells , or tumor-initiating cells, today highlighted data from several clinical studies that will be presented at the upcoming American Society for Clinical Oncology Annual Meeting being held May 30 - June 3, 2014 in Chicago, IL.
http://ift.tt/1stUbGA
http://ift.tt/1stUbGA
No comments:
Post a Comment